High Mark Wealth Management LLC Karuna Therapeutics, Inc. Transaction History

High Mark Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 18, 2023	SELL	$164.66 - $218.08 $3,293 - $4,361	-20 Reduced 26.67%	55 $9,000
Q4 2021 Jan 20, 2022	SELL	$110.64 - $159.4 $14,383 - $20,722	-130 Reduced 63.41%	75 $10,000
Q3 2021 Nov 01, 2021	BUY	$101.2 - $125.87 $1,821 - $2,265	18 Added 9.63%	205 $25,000
Q2 2021 Aug 02, 2021	BUY	$107.45 - $135.95 $1,826 - $2,311	17 Added 10.0%	187 $21,000
Q1 2021 Apr 22, 2021	BUY	$95.46 - $133.08 $16,228 - $22,623	170 New	170 $20,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on High Mark Wealth Management LLC with notifications on news.